High mobility group box 1 mediates inflammatory response of astrocytes via cyclooxygenase 2/prostagl

来源 :中国神经再生研究(英文版) | 被引量 : 0次 | 上传用户:ilovelp222222
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
High mobility group box 1(HMGB1)interacts with pattern-recognition receptors of immune cells to activate the inflammatory response.Astrocytes play a positive role in the inflammatory response of the central nervous system by expressing a broad range of pattern-recognition receptors.However,the underlying relationship between HMGB1 and the inflammatory reaction of astrocytes remains unclear.In this study,we established rat models of spinal cord injury via laminectomy at the T8-10 level,and the injured spinal cord was subjected to transcriptome sequencing.Our results showed that the HMGB1/Toll-like receptor 4(TLR4)axis was involved in the activation of astrocyte inflammatory response through regulation of cyclooxygenase 2(COX2)/prostaglandin E2(PGE2)signaling.Both TLR4 and COX2 were distributed in astrocytes and showed elevated protein levels following spinal cord injury.Stimulation of primary astrocytes with recombinant HMGB1 showed that COX2 and microsomal PGE synthase(mPGES)-1,rather than COX1,mPGES-2,or cytosolic PGE synthase,were significantly upregulated.Accordingly,PGE2 production in astrocytes was remarkably increased in response to recombinant HMGB1 challenges.Pharmacologic blockade of TLR2/4 attenuated HMGB1-mediated activation of the COX2/PGE2 pathway.Interestingly,HMGB1 did not impact the production of tumor necrosis factor-α or interleukin-1β in astrocytes.Our results suggest that HMGB1 mediates the astrocyte inflammatory response through regulating the COX2/PGE2 signaling pathway.The study was approved by the Laboratory Animal Ethics Committee of Nantong University,China(approval No.20181204-001)on December 4,2018.
其他文献
脑卒中严重危害人类健康和生命,是我国成年人致死和致残的首位原因,且发病率逐年增高.缺血性脑卒中发作后,随着时间的推移大多数患者会出现一定程度的自我恢复.脑缺血后的神
selumetinib(商品名:Koselugo?)是一种口服、强效、选择性MEK1/2激酶抑制剂,也是首个获美国FDA批准的治疗小儿1型神经纤维瘤病(NF1)相关的症状性、不能手术的丛状神经纤维瘤(